Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anthony Jerome Thomas"'
Autor:
D.W. Moreland, Juan C. Jaen, Penvose-Yi, Roy D. Schwarz, C.E. Augelli-Szafran, C. J. Blankley, Anthony Jerome Thomas, C.B. Nelson
Publikováno v:
Journal of Medicinal Chemistry. 42:356-363
A series of esters of 1,4-disubstituted tetrahydropyridine carboxylic acids (I) has been synthesized and characterized as potential m1 selective muscarinic receptor antagonists. The affinity of these compounds for the five human muscarinic receptor s
Autor:
Bradley William Caprathe, Haile Tecle, Stephen Douglas Barrett, Juan C. Jaen, Anthony Jerome Thomas
Publikováno v:
Organic Preparations and Procedures International. 29:330-335
Autor:
R.D. Schwan, Anthony Jerome Thomas, D.W. Moreland, Haile Tecle, Juan C. Jaen, T. Mirzadegan, Lauffer David Jeffrey, Charlotte Raby, David Eubanks, Mark R. Brann, Robert E. Davis
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:637-642
Synthesis and SAR of a new class of 1-azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oxime muscarinic agonists are described. Depending on the geometry of the C=N and C=C bonds, subnanomolar potency and/or high efficacy are achiev
Autor:
Haile Tecle, Robert E. Davis, Roy D. Schwarz, Bradley William Caprathe, T. Mirzadegan, Stephen Douglas Barrett, Walter H. Moos, Lauffer David Jeffrey, Juan C. Jaen, Anthony Jerome Thomas, D.W. Moreland, Michael R. Pavia, C.E. Augelli-Szafran
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:631-636
The synthesis and SAR of a series of Z-(±)-1-azabicyclo[2.2.1]heptan-3-one, O-(3-aryl-2-propynyl) oximes are described. The biochemistry and pharmacology of PD 142505 (5b), an oxime with pronounced functional ml selectivity, are highlighted.
Autor:
Haile Tecle, Roy D. Schwarz, D.W. Moreland, Anthony Jerome Thomas, T. Mirzadegan, Carolyn J. Spencer, Juan C. Jaen
Publikováno v:
Life Sciences. 56:923-929
Aspartate 103 (D103) in the third transmembrane domain of the Hm2 receptor was mutated to glutamate (D103E), asparagine (D103N), or alanine (D103A). As measured by [3H]-NMS, no significant binding was observed in D103A, while a 2-fold decrease in lig
Autor:
Susan Fisher, Anthony Jerome Thomas, Sharie L. Myers, Michael R. Pavia, Walter H. Moos, Kathryn B. Sanders, Robert E. Davis, Linda L. Coughenour
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 2:803-808
There is considerable interest in muscarinic acetylcholine receptor (mAChR) subtype selective agents as cholinomimetics for the treatment of senile dementia of the Alzheimer's type (SDAT). A series of substituted analogs similar to the muscarinic ago
Autor:
Walter H. Moos, Roy D. Schwarz, Fred M. Hershenson, James P. Symons, Anthony Jerome Thomas, John G. Marriott, Carolyn J. Spencer, Jeffrey Alan Kester, Donald E. Butler, Robert E. Davis
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 2:855-860
We have sought to improve upon the activity of the well known AcCh-releasing agents, 4-aminopyridine and 3,4-diaminopyridine. This work has led to the discovery of a series of ureas with AcCh-releasing properties. From this series, compound 5 has eme
Autor:
Robert E. Davis, Haile Tecle, Bradley William Caprathe, Mark R. Emmerling, Anthony Jerome Thomas, Michael J. Callahan, Roy D. Schwarz, C.B. Nelson, Juan C. Jaen, Katharyn Spiegel, P.D. Doyle, Stephen Douglas Barrett, Charlotte Raby, D.W. Moreland, W Lipiniski, Carolyn J. Spencer, T. Mirzadegan, Lauffer David Jeffrey
Publikováno v:
Pharmaceutica acta Helvetiae. 74(2-3)
The five muscarinic receptor subtypes (M 1 –M 5 ) are characterized by seven helices that define a transmembrane cavity which serves as the binding pocket for agonists and antagonists. The five cavities appear to be topographically different enough
Publikováno v:
Life Sciences. 56:1020
Autor:
J.R. Penvose, C.B. Nelson, C.E. Augelli-Szafran, Roy D. Schwarz, Anthony Jerome Thomas, Juan C. Jaen, C. Christoffersen, Michael J. Callahan, James N. Wiley, L.T. Meltzer
Publikováno v:
Life Sciences. 56:1017